BioLargo, Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 5/10/2016
Contact Info
  • 14921 Chestnut St.
  • Westminster, CA 92683

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2016 10-Q
CIK 0000880242
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2800 - Chemicals & Allied Products
Business Status Development Stage Company a/o Jan 01, 2015
Incorporated In: DE, USA
Year of Inc. 1987
Employees 9 a/o Dec 31, 2015
Company Officers/Contacts
Dennis Calvert President, CEO, IR
Charles Dargan II CFO
Joseph Provenzano Secretary
Kenneth Code CSO
AJ Sexton V Director, Bus. Dev.
John Browning General Counsel
Company Directors
Dennis Calvert
Gary Cox
Kent C. Roberts II
Dennis Marshall
Joseph Provenzano
Kent Roberts
John S. Runyan
Company Notes
  • Formerly=NuWay Medical, Inc. until 3-07
  • Formerly=NuWay Energy, Inc. until 11-02
  • Formerly=Latin American Casinos, Inc. until 8-01
  • Formerly=Repossession Auction, Inc. to 6-94
Service Providers
Accounting/Auditing Firm
Haskell & White LLP
300 Spectrum Drive
Suite 300
Irvine, CA, 92618
United States

Legal Counsel
Law Offices of John R. Browning
2603 Main Street
Ste. 1050
Irvine, CA, 92614
United States

Investor Relations Firm
UPTICK Newswire
10000 N 31st Ave
Suite C-105
Phoenix, AZ, 85051
United States

BLGO Security Details
Share Structure
Market Value1 $60,086,065 a/o Oct 21, 2016
Authorized Shares 200,000,000 a/o May 06, 2016
Outstanding Shares 87,081,254 a/o Aug 04, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 27,022,652 a/o Apr 28, 2016
Par Value 0.00067
Shareholders of Record 660 a/o Mar 30, 2016
Short Selling Data
Short Interest 327,209 (-20.74%)
Sep 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security